Alfredo Perales-Puchalt

6PUBLICATIONS
45CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 07, 2024
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial.

Mark Yarchoan, Edward J Gane, Thomas U Marron

|Dec 05, 2023
Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation.

Kristine A Frerichs, Christie P M Verkleij, Maria Victoria Mateos

|Nov 01, 2023
Siglec-7 glyco-immune binding mAbs or NK cell engager biologics induce potent antitumor immunity against ovarian cancers.

Devivasha Bordoloi, Abhijeet J Kulkarni, Opeyemi S Adeniji

|Aug 22, 2020
BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells.

Kyle K Payne, Jessica A Mine, Subir Biswas

|Feb 20, 2019
Engineered transfer RNAs for suppression of premature termination codons.

John D Lueck, Jae Seok Yoon, Alfredo Perales-Puchalt

|Dec 15, 2018
IL-33 delays metastatic peritoneal cancer progression inducing an allergic microenvironment.

Alfredo Perales-Puchalt, Nikolaos Svoronos, Daniel O Villarreal

Pageof 1

Frequent Collaborators

2 joint publications

David B Weiner

1 joint publications

Elizabeth K Duperret

1 joint publications

Mark A Behlke

1 joint publications

Christopher A Ahern